A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer
Status:
Terminated
Trial end date:
2010-03-03
Target enrollment:
Participant gender:
Summary
This study aim was to determine the safety and efficacy of R1507 in combination with
letrozole in patients with advanced breast cancer. In the first part of the study a cohort of
patients with advanced breast cancer received letrozole 2.5mg po daily in combination with
R1507 16mg/kg every 3 weeks.